Are Chronic Hepatitis B Carriers Contagious?

Individuals with chronic hepatitis B virus (HBV) infection—often referred to as “chronic HBV carriers”—are indeed infectious. This is because the virus persists in the liver and circulates in the bloodstream, where it can be detected via serologic markers such as hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and HBV DNA.

Transmission occurs primarily through percutaneous or mucosal exposure to infectious body fluids—including blood, semen, and vaginal secretions. Common routes include unprotected sexual contact, sharing of needles or syringes, accidental needlestick injuries, and from mother to child during childbirth (perinatal transmission). While saliva, tears, and sweat contain negligible or undetectable levels of HBV, transmission via casual contact—such as hugging, sharing utensils, or kissing on the cheek—is not supported by epidemiologic evidence.

It is important to note that infectivity varies depending on viral load and serologic profile. Individuals who are HBeAg-positive typically have high levels of HBV DNA and are more contagious. Conversely, those who are HBeAg-negative but HBV DNA–positive—particularly those with precore or core promoter variants—may still transmit the virus, albeit often at lower efficiency. Even individuals with low-level viremia (<2,000 IU/mL) remain potentially infectious, especially in healthcare or household settings involving direct blood exposure.

Prevention hinges on universal precautions, vaccination of susceptible contacts, and antiviral therapy for eligible patients to suppress viral replication and reduce transmission risk. All chronic HBV carriers should undergo regular monitoring—including liver function tests, quantitative HBV DNA, and hepatocellular carcinoma surveillance—to guide clinical management and public health interventions.